Close

BSTC Financial Facts

Diluted net income (loss) per share: 0.42
Total Cost and Expenses: 2.16M
See Full Income Statement

Deferred tax assets -long term: 3.37M
Total stockholders' equity: 53.22M
See Full Balance Sheet

BioSpecifics Technologies Corp. (BSTC) Earnings

  |   Expand Research on BSTC
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -0.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/11/11 Q410 $0.02-$0.04 +$0.06$1.1M$1.38M N/A Details
3/9/12 Q411 $0.01N/A N/A $2.6M$1.1M N/A Details
8/9/12 Q212 $0.11$0.07 +$0.04$2.6M$2.5M N/A Details
5/8/14 Q114 $0.12$0.07 +$0.05$2.8M$2.46M N/A Details
11/8/11 Q311 $0.04N/A N/A $1.9M$1M N/A Details
8/10/15 Q215 $0.24N/A N/A $4.7M$2.6M N/A Details
5/11/15 Q414 $0.32N/A N/A $5.6M$2.3M N/A Details
8/11/14 Q214 $0.09$0.12 -$0.03$2.7M$2.91M N/A Details